Pharmacologic therapies for obesity
- PMID: 20202580
- DOI: 10.1016/j.gtc.2010.01.001
Pharmacologic therapies for obesity
Abstract
This article examines the transitions in pharmacological therapy for obesity. It reviews the current options approved by the Food and Drug Administration and several drugs approved for other indications that can be used to treat obesity as well. Because weight regulation is complex and redundant systems protect against perceived starvation, optimal treatment of obesity in individual patients will likely require different combinations of behavioral, nutritional, pharmacologic, endoscopic, and surgical therapies.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Pharmacological therapies for obesity.Gastroenterol Clin North Am. 2005 Mar;34(1):91-104. doi: 10.1016/j.gtc.2004.12.002. Gastroenterol Clin North Am. 2005. PMID: 15823441 Review.
-
Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16. Expert Rev Cardiovasc Ther. 2010. PMID: 20707765 Review.
-
Pharmacotherapy for obesity: What you need to know.Cleve Clin J Med. 2017 Dec;84(12):951-958. doi: 10.3949/ccjm.84a.16094. Cleve Clin J Med. 2017. PMID: 29244650 Review.
-
[Weight reduction. Antiobesity drug treatment in type-2 diabetics].Pharm Unserer Zeit. 2002;31(3):300-7. doi: 10.1002/1615-1003(200205)31:3<300::AID-PAUZ300>3.0.CO;2-C. Pharm Unserer Zeit. 2002. PMID: 12071127 Review. German. No abstract available.
-
[Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].MMW Fortschr Med. 2003 Mar 6;145(10):16. MMW Fortschr Med. 2003. PMID: 12688021 German. No abstract available.
Cited by
-
Lorcaserin for the treatment of obesity.Drugs Today (Barc). 2010 Dec;46(12):901-10. doi: 10.1358/dot.2010.46.12.1556433. Drugs Today (Barc). 2010. PMID: 21589947 Free PMC article. Review.
-
New pharmacological treatments for the management of obesity.Curr Gastroenterol Rep. 2014;16(6):394. doi: 10.1007/s11894-014-0394-0. Curr Gastroenterol Rep. 2014. PMID: 24828101 Review.
-
Enhanced peroxisomal β-oxidation metabolism in visceral adipose tissues of high-fat diet-fed obesity-resistant C57BL/6 mice.Exp Ther Med. 2011 Mar;2(2):309-315. doi: 10.3892/etm.2011.208. Epub 2011 Jan 20. Exp Ther Med. 2011. PMID: 22977503 Free PMC article.
-
Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty.PLoS One. 2013;8(4):e60280. doi: 10.1371/journal.pone.0060280. Epub 2013 Apr 3. PLoS One. 2013. PMID: 23573244 Free PMC article.
-
Heritability of the weight loss response to gastric bypass surgery.J Clin Endocrinol Metab. 2011 Oct;96(10):E1630-3. doi: 10.1210/jc.2011-1130. Epub 2011 Aug 10. J Clin Endocrinol Metab. 2011. PMID: 21832118 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical